AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32071465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic subgingival debridement combined with manual root planing
Number of subjects: 23
Study 32071465 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic subgingival debridement
Number of subjects: 23
Study 35856588 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (di)gluconate lock solution (CHGLS)
Number of subjects: 100
Study 35856588 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 34370327 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise programme (G1)
Number of subjects: 45
Study 34370327 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic and aerobic exercise programme (G2)
Number of subjects: 45
Study 34370327 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise programme (G3)
Number of subjects: 45
Study 32559644 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with continuous stochastic perturbations
Number of subjects: 21
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori positive
Number of subjects: 3001
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori negative
Number of subjects: 3001
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 3001
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee consumption
Number of subjects: 3001
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: Onion consumption
Number of subjects: 3001
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: Former smoking
Number of subjects: 3001
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: Pickled product consumption
Number of subjects: 3001
Study 35131967 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor use
Number of subjects: 3001
Study 34909917 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pilocarpine (20 mg daily)
Number of subjects: 32
Study 34909917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33639559 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of feedback and modeling
Number of subjects: 32
Study 33639559 — intervention group
Group type: COMPARATOR
Intervention: Feedback alone
Number of subjects: 32
Study 33639559 — intervention group
Group type: COMPARATOR
Intervention: Modeling alone
Number of subjects: 32
Study 36121443 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing voucher redeemable in a low-poverty neighborhood plus housing counseling
Number of subjects: 4600
Study 36121443 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing voucher without locational restriction
Number of subjects: 4600
Study 36121443 — intervention group
Group type: COMPARATOR
Intervention: No voucher (control)
Number of subjects: 4600
Study 33906609 — intervention group
Group type: COMPARATOR
Intervention: Initial heparin dose of 100 U/kg (Warfarin group)
Number of subjects: 187
Study 33906609 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial heparin dose of 110 U/kg (NOAC group)
Number of subjects: 187
Study 33906609 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial heparin dose of 120 U/kg (NOAC group)
Number of subjects: 187
Study 33906609 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial heparin dose of 130 U/kg (NOAC group)
Number of subjects: 187
Study 33402626 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive distraction (ID) with handheld video game (HVG)
Number of subjects: 30
Study 33402626 — intervention group
Group type: COMPARATOR
Intervention: Parent-provided distraction (PPD)
Number of subjects: 30
Study 33402626 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse rate in PPD group
Number of subjects: 30
Study 33402626 — intervention group
Group type: COMPARATOR
Intervention: Pulse rate
Number of subjects: 30
Study 33402626 — intervention group
Group type: COMPARATOR
Intervention: FLACC scores
Number of subjects: 30
Study 32602755 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical oxymetazoline (OXZ) 1.5% in liposomal base
Number of subjects: 40
Study 32602755 — intervention group
Group type: COMPARATOR
Intervention: Topical lipogel (control)
Number of subjects: 40
Study 33595845 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab 30 mg SC
Number of subjects: 24
Study 33595845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33157937 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week lifestyle change promotion program
Number of subjects: 180
Study 33157937 — intervention group
Group type: COMPARATOR
Intervention: 8-week mindfulness-based cognitive therapy program
Number of subjects: 180
Study 33157937 — intervention group
Group type: COMPARATOR
Intervention: Written suggestions for lifestyle changes
Number of subjects: 180
Study 36122912 — intervention group
Group type: EXPERIMENTAL
Intervention: Four implants
Number of subjects: 50
Study 36122912 — intervention group
Group type: COMPARATOR
Intervention: Six implants
Number of subjects: 50
Study 34444984 — intervention group
Group type: EXPERIMENTAL
Intervention: Social norms-based intervention (RANI Project)
Number of subjects: 0
Study 34444984 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 616063206 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation with legal support and services
Number of subjects: 103
Study 616063206 — intervention group
Group type: COMPARATOR
Intervention: Patient navigation without legal support and services
Number of subjects: 103
Study 36038894 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth application 'alley' as an adjuvant intervention to TJA
Number of subjects: 400
Study 36038894 — intervention group
Group type: COMPARATOR
Intervention: Control group (no access to the app)
Number of subjects: 400
Study 34508602 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote nurse-led symptom care manager (RN SCM) phone call
Number of subjects: 864
Study 34508602 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-out framing for receiving RN SCM calls
Number of subjects: 864
Study 34508602 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving care at a tertiary care center
Number of subjects: 864
Study 34508602 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe pain
Number of subjects: 864
Study 34764014 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at the BL67 point for 10 minutes daily for two consecutive weeks
Number of subjects: 138
Study 34764014 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 138
Study 34764014 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at the BL67 point
Number of subjects: 138
Study 32408883 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (NAVA)
Number of subjects: 78
Study 36206239 — intervention group
Group type: EXPERIMENTAL
Intervention: Technological visuo-cognitive training (TVT)
Number of subjects: 40
Study 36206239 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study 32829494 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 50
Study 32829494 — intervention group
Group type: COMPARATOR
Intervention: Control (waiting list)
Number of subjects: 50
Study 33169493 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic sleep restriction (5-hr time in bed for 5 nights)
Number of subjects: 36
Study 33169493 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute sleep deprivation (38 hours after 1 night of recovery sleep with 8-hr TIB)
Number of subjects: 36
Study 33169493 — intervention group
Group type: COMPARATOR
Intervention: Control group (8-hr time in bed for 5 nights)
Number of subjects: 36
Study 33169493 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery sleep (10-hr TIB) after acute sleep deprivation
Number of subjects: 36
Study 32407827 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective practice intervention
Number of subjects: 0
Study 32407827 — intervention group
Group type: COMPARATOR
Intervention: Video alone
Number of subjects: 0
Study 35510486 — intervention group
Group type: EXPERIMENTAL
Intervention: Imetelstat 9.4 mg/kg administered as an intravenous infusion every 21 days
Number of subjects: 0
Study 35510486 — intervention group
Group type: COMPARATOR
Intervention: Best available therapy, excluding JAK inhibitors
Number of subjects: 0
Study 33243811 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised physical exercise training programmes combined with increased protein intake (IPET+P) receiving 27.5 g protein/day
Number of subjects: 0
Study 33243811 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 33243811 — intervention group
Group type: COMPARATOR
Intervention: Usual care with protein supplementation (UC+P) receiving 27.5 g protein/day
Number of subjects: 0
Study 36037324 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based emotion management intervention (80 minutes, once per week for 4 weeks)
Number of subjects: 72
Study 32744354 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg or 25mg
Number of subjects: 6152
Study 32744354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6152
Study 36658596 — intervention group
Group type: EXPERIMENTAL
Intervention: LessStress prevention training programme (90 minutes duration)
Number of subjects: 1894
Study 36658596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1894
Study 34207231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional education intervention with follow-up session one year later
Number of subjects: 261
Study 34207231 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 261
Study 35703114 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative rate of steatorrhea at 1 year
Number of subjects: 1633
Study 35703114 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative rate of steatorrhea at 3 years
Number of subjects: 1633
Study 35703114 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative rate of steatorrhea at 5 years
Number of subjects: 1633
Study 35703114 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factor - Male sex
Number of subjects: 1633
Study 35703114 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factor - Diabetes mellitus at/before diagnosis of ICP
Number of subjects: 1633
Study 35703114 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factor - Aged less than 18 years at onset of ICP
Number of subjects: 1633
Study 32113823 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 60
Study 32113823 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone
Number of subjects: 60
Study 35780048 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus radical local therapy (RLT)
Number of subjects: 200
Study 35780048 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 200
Study 35109568 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Patterns intervention
Number of subjects: 170
Study 36367426 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Interview
Number of subjects: 75
Study 36367426 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Problem Solving
Number of subjects: 75
Study 36367426 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (OSHA safety cards)
Number of subjects: 75
Study 36227238 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Selected Music (SSM)
Number of subjects: 17
Study 36227238 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 17
Study 36227238 — intervention group
Group type: COMPARATOR
Intervention: None (Control)
Number of subjects: 17
Study 36375189 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal endoscopic lumbar discectomy (TELD)
Number of subjects: 91
Study 36375189 — intervention group
Group type: COMPARATOR
Intervention: Interlaminar endoscopic lumbar discectomy (IELD)
Number of subjects: 91
Study 33016711 — intervention group
Group type: EXPERIMENTAL
Intervention: Kernel machine operating on data grouped into equally labeled subsets
Number of subjects: 0
Study 33016711 — intervention group
Group type: EXPERIMENTAL
Intervention: Margin classifiers with randomly labeled data
Number of subjects: 0
Study 35190177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg intravenously on days 1, 15, and 29; n = 23)
Number of subjects: 44
Study 35190177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab with ipilimumab (1 mg/kg intravenously on day 1; n = 21)
Number of subjects: 44
Study 35190177 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab or Nivolumab with ipilimumab
Number of subjects: 44
Study 34702332 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (post‐tetanic count 1‐2 twitches)
Number of subjects: 922
Study 34702332 — intervention group
Group type: COMPARATOR
Intervention: Standard care (single‐dose muscle relaxant administration at induction)
Number of subjects: 922
Study 34702332 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block
Number of subjects: 922
Study 33652495 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G Franseen needle
Number of subjects: 140
Study 33652495 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G Franseen needle
Number of subjects: 140
Study 32886321 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs) - Dabigatran (66%), Apixaban (21%), Rivaroxaban (13%); 58% prescribed reduced dose.
Number of subjects: 566
Study 33586606 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatrombopag
Number of subjects: 49
Study 33586606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 32603357 — intervention group
Group type: EXPERIMENTAL
Intervention: P-sha (novel needle guide)
Number of subjects: 35
Study 32603357 — intervention group
Group type: COMPARATOR
Intervention: P-com (commercial needle guide)
Number of subjects: 35
Study 32603357 — intervention group
Group type: COMPARATOR
Intervention: P-free (free-hand placement)
Number of subjects: 35
Study 35562830 — intervention group
Group type: EXPERIMENTAL
Intervention: Meridian theory-based extracorporeal shock wave therapy (ESWT)
Number of subjects: 66
Study 35562830 — intervention group
Group type: COMPARATOR
Intervention: Conventional extracorporeal shock wave therapy (ESWT)
Number of subjects: 66
Study 34168037 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 824
Study 34168037 — intervention group
Group type: COMPARATOR
Intervention: In vitro fertilisation (IVF)
Number of subjects: 824
Study 32907352 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% patchouli oil in sweet almond oil (patchouli group)
Number of subjects: 50
Study 32907352 — intervention group
Group type: COMPARATOR
Intervention: Pure sweet almond oil (control group)
Number of subjects: 50
Study 34053097 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality glasses for distraction
Number of subjects: 100
Study 34053097 — intervention group
Group type: COMPARATOR
Intervention: Control group (no distraction)
Number of subjects: 100
Study 33490019 — intervention group
Group type: COMPARATOR
Intervention: Low education level
Number of subjects: 37922
Study 33490019 — intervention group
Group type: COMPARATOR
Intervention: Per capita monthly income
Number of subjects: 37922
Study 33490019 — intervention group
Group type: COMPARATOR
Intervention: Low education level and physical activity (PA) interaction
Number of subjects: 37922
Study 35648204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training intervention
Number of subjects: 36
Study 35648204 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 36
Study 33676295 — intervention group
Group type: EXPERIMENTAL
Intervention: CMS classification
Number of subjects: 679
Study 33676295 — intervention group
Group type: EXPERIMENTAL
Intervention: CRCA classification
Number of subjects: 679
Study 33676295 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOXIRI treatment
Number of subjects: 679
Study 35588050 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg subcutaneously every 4 weeks for 6 cycles
Number of subjects: 780
Study 35588050 — intervention group
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel 125 mg/m2 weekly for 12 weeks
Number of subjects: 780
Study 35588050 — intervention group
Group type: COMPARATOR
Intervention: Nab-paclitaxel days 1 and 8 every 3 weeks for 4 cycles (8 doses)
Number of subjects: 780
Study 35588050 — intervention group
Group type: COMPARATOR
Intervention: Denosumab (with or without)
Number of subjects: 780
Study 35588050 — intervention group
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel weekly
Number of subjects: 780
Study 33298509 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix2 coils
Number of subjects: 626
Study 33298509 — intervention group
Group type: COMPARATOR
Intervention: Bare metal coils (BMCs)
Number of subjects: 626
Study 33298509 — intervention group
Group type: EXPERIMENTAL
Intervention: Unruptured aneurysms
Number of subjects: 626
Study 33298509 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruptured aneurysms
Number of subjects: 626
Study 34448342 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 60
Study 34448342 — intervention group
Group type: COMPARATOR
Intervention: Tackers
Number of subjects: 60
Study 32581121 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Empowerment narrative
Number of subjects: 565
Study 32581121 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Empowerment narrative
Number of subjects: 565
Study 32581121 — intervention group
Group type: COMPARATOR
Intervention: Poverty Alleviation narrative
Number of subjects: 565
Study 32581121 — intervention group
Group type: EXPERIMENTAL
Intervention: Local forecasting methodology
Number of subjects: 565
Study 32581121 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative most effective for recipients
Number of subjects: 565
Study 32223963 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency ventilation (LFV) during CPB
Number of subjects: 37
Study 32223963 — intervention group
Group type: COMPARATOR
Intervention: Lungs left collapsed during CPB
Number of subjects: 37
Study 35960902 — intervention group
Group type: EXPERIMENTAL
Intervention: Rucaparib 600 mg twice a day orally
Number of subjects: 40
Study 35960902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35960902 — intervention group
Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 40
Study 33880833 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram composed of preoperative variables
Number of subjects: 999
Study 33880833 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram validation
Number of subjects: 999
Study 32316331 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 54
Study 32316331 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy group
Number of subjects: 54
Study 32316331 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 35190371 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary collection devices (UCDs)
Number of subjects: 29
Study 35190371 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of clear information
Number of subjects: 29
Study 35190371 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing of information derived from uncontaminated samples
Number of subjects: 29
Study 34154627 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35657133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF)
Number of subjects: 793
Study 35657133 — intervention group
Group type: COMPARATOR
Intervention: Elbasvir/Grazoprevir (EBR/GZR)
Number of subjects: 793
Study 32646561 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg every 2 weeks
Number of subjects: 69
Study 32646561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 32646561 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 69
Study 36203323 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cTBS treatment
Number of subjects: 54
Study 36203323 — intervention group
Group type: COMPARATOR
Intervention: Sham cTBS treatment
Number of subjects: 54
Study 33269455 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenic protein-1 (OP-1)
Number of subjects: 41
Study 33269455 — intervention group
Group type: COMPARATOR
Intervention: Autograft
Number of subjects: 41
Study 35963797 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse led triage intervention
Number of subjects: 0
Study 36250353 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad faces gazing upwards
Number of subjects: 0
Study 36250353 — intervention group
Group type: COMPARATOR
Intervention: Sad faces gazing downwards
Number of subjects: 0
Study 36250353 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental frame of reference
Number of subjects: 0
Study 36250353 — intervention group
Group type: COMPARATOR
Intervention: Happy faces
Number of subjects: 0
Study 32096437 — intervention group
Group type: EXPERIMENTAL
Intervention: Manually corrected wild-type and perL mutant songs
Number of subjects: 0
Study 32096437 — intervention group
Group type: COMPARATOR
Intervention: Lomb-Scargle (L-S) periodogram
Number of subjects: 0
Study 32096437 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization of locomotor and song data
Number of subjects: 0
Study 32096437 — intervention group
Group type: EXPERIMENTAL
Intervention: Other time-series analyses
Number of subjects: 0
Study 34860705 — intervention group
Group type: EXPERIMENTAL
Intervention: Naringenin supplementation
Number of subjects: 44
Study 34860705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32297539 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian methods for pilot studies
Number of subjects: 0
Study 36108849 — intervention group
Group type: EXPERIMENTAL
Intervention: SPORTS group (2000 m jogging in 20 min for 3 times in 4 days)
Number of subjects: 55
Study 36108849 — intervention group
Group type: COMPARATOR
Intervention: CON group (no intervention)
Number of subjects: 55
Study 36108849 — intervention group
Group type: EXPERIMENTAL
Intervention: SPORTS group
Number of subjects: 55